Intra-Cellular Therapies Inc. (ITCI) Climbed 7.37% or 1.4 To Price $20.32 On Friday


Intra-Cellular Therapies Inc. (ITCI) climbed 7.37% or 1.4 to $20.32. It is nearly 477091 shares traded, which is 136.23% compare to the average total volume 350201. The market cap of ITCI is $1.11 billion. The year to date change is 32.18%. The 52 week price range is from $10.25 to $25.82. Price of ITCI have changed 6.41% during last week. It have changed -14.81% over last month, -3.62% over last 3 months, 8.30% over last 6 months and 47.58% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ITCI is 20.33. It is 0.05% above current price. The stock faces resistance at 50-day moving averages. The 200-day Moving Averages for ITCI is 18.43. It is -9.30% below current price. The 52-week High is 25.82. It is 27.07% from the current price. The 52-week Low is 10.25. It is -49.56% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ITCI is 13.24 on 2018-06-15. Short % to float is 6.75%. There are some statistics of ITCI. It is has market cap $1.11 billion. The share outstanding is 54.70 million. The average volume is 350201. The revenue is 145495. The percent of top 15 Institution holding is 79.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ITCI is -25.57%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ITCI is -24.26%.


Tags:

Share this post